Positive and negative regulation of adenovirus infection by CAR-like soluble protein, CLSP

Gene Therapy

Volumn 14, Issue 16, 2007, Pages 1199-1207

  Kawabata, K ^a   Tashiro, K ^a,b   Sakurai, F ^a   Osada, N ^a   Kusuda, J ^a   Hayakawa, T ^c   Yamanishi, K ^a,b   Mizuguchi, H ^a,b  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c PHARMACEUTICALS AND MEDICAL DEVICES AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; AMINO ACID; COMPLEMENTARY DNA; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR LIKE SOLUBLE PROTEIN; IMMUNOGLOBULIN; MESSENGER RNA; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL TISSUE; ARTICLE; BRAIN; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENETIC DATABASE; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; VIRUS INFECTION; WESTERN BLOTTING;

3T3 CELLS; ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATTLE; CELL LINE; CHICKENS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; ESCHERICHIA COLI PROTEINS; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE ELONGATION FACTORS; PROTEINS; RATS; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION;

ADENOVIRIDAE; ANIMALIA; BOVINAE; COXSACKIEVIRUS; HUMAN ENTEROVIRUS B; RODENTIA;

EID: 34547656097     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302975     Document Type: Article

References (41)

1. Bergelson JM, Krithivas A, Celi L, Droguett G, Horwitz MS, Wickham T et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
2. Tomko Rp, Xu R, Philipson L. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997; 94: 3352-3356.
3. Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM, Finberg RW et al. The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 1998; 72: 7909-7915.
4. Bergelson JM, Krithivas A, Celi L, Droguett G, Horwitz MS, Wickham T et al. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol 1998; 72: 415-419.
5. van Raaij MJ, Chouin E, van der Zandt H, Bergelson JM, Cusack S. Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1.7 A resolution. Structure 2060; 8: 1147-1155.
6. Howitt J, Bewley MC, Graziano V, Flanagan JM, Freimuth P. Structural basis for variation in adenovirus affinity for the cellular coxsackievirus and adenovirus receptor. J Biol Chem 2003; 278 26208-26215.
7. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson, JM. The coxsackievirus and adenovirus receptor is a trans-membrane component of the tight junction. Proc Natl Acad Sci USA 2001; 98: 15191-15196.
8. Walters RW, Freimuth P, Moninger TO, Ganske I, Zabner J, Welsh MJ. Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape. Cell 2002, 110: 789-799.
9. Coyne CB, Bergelson JM. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 2006; 12: 119-131.
10. Okegawa T, Pong RC, Li Y, Bergelson JM, Sagalowsky AI, Hsieh JT. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: A functional analysis of CAR protein structure. Cancer Res 2001; 61: 6592-6600.
11. Huang KC, Altinoz M, Wosik K, Larochelle N, Koty Z, Zhu L et al. Impact of the coxsackie and adenovirus receptor (CAR) on glioma cell growth and invasion: Requirement for the C-terminal domain. Int J Cancer 2005; 113: 738-745.
12. Asher DR, Cerny AM, Weiler SR, Horner JW, Keeler ML, Neptune MA et al. Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development. Genesis 2005; 42: 77-85.
13. Dorner AA, Wegmann F, Butz S, Wolburg-Buchholz K, Wolburg H, Mack A et al. Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development. J Cell Sci 2005; 118: 3509-3521.
14. Williams AF, Barclay AN. The immunoglobulin superfamily - domains for cell surface recognition. Annu Rev Immunol 1988; 6: 381-405.
15. Raschperger E, Engstrom U, Pettersson RF, Fuxe J. CLMP, a novel member of the CTX family and a new component of epithelial tight junctions. J Biol Chem 2004; 279: 796-804.
16. Suzu S, Hayashi Y, Harumi T, Nomaguchi K, Yamada M, Hayasawa H et al. Molecular cloning of a novel immunoglobulin superfamily gene preferentially expressed by brain and testis. Biochem Biophys Res Commun 2002; 296: 1215-1221.
17. Hirata K, Ishida T, Penta K, Rezaee M, Yang E, Wohlgemuth J et al. Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells. J Biol Chem 2001; 276: 16223-16231.
18. Fernandez-Botran R, Chilton PM, Ma Y. Soluble cytokine receptors: Their roles in immunoregulation, disease, and therapy. Adv Immunol 1996; 63: 269-336.
19. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM. The soluble interleukin 6 receptor: Mechanisms of production and implications in disease. FASEB J 2001; 15: 43-58.
20. Soldan SS, Fogdell-Hahn A, Brennan MB, Mittleman BB, Ballerini C, Massacesi L et al. Elevated serum and cerebrospinal fluid levels of soluble a human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Ann Neurol 2001; 50: 486-493.
21. Dorner A, Xiong D, Couch K, Yajima T, Knowlton KU. Alternatively spliced soluble coxsackie-adenovirus receptors inhibit coxsackievirus infection. J Biol Chem 2004; 279: 18497-18503.
22. Bernal RM, Sharma S, Gardner BK, Douglas JT, Bergelson JM, Dubinett SM et al. Soluble coxsackievirus adenovirus receptor is a putative inhibitor of adenoviral gene transfer in the tumor milieu. Clin Cancer Res 2002; 8: 1915-1923.
23. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 1986; 44: 283-292.
24. Lagnado CA, Brown CY, Goodall GJ. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: The functional sequence within AU rich elements may be UUAUUUA(U/A)(U/A). Mol Cell Biol 1994; 14: 7984-7995.
25. von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res 1986; 14: 4683-4690.
26. Freimuth P, Springer K, Berard C, Hainfeld J, Bewley M, Flanagan J. Coxsackievirus and adenovirus receptor amino-terminal immunoglobulin V-related domain binds adenovirus type 2 and fiber knob from adenovirus type 12. J Virol 1999, 73: 1392-1398.
27. Mizuguchi H, Koizumi N, Hosono T, Utoguchi N, Watanabe Y, Kay MA et al. A simplified system for constructing recombmant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Therapy 2001; 8: 730-735.
28. Nelson JE, Kay MA. Persistence of recombinant adenovirus in vivo is not dependent on vector DNA replication. J Virol 1997; 71 8902-8907.
29. Segerman A, Atkinson JP, Marttila M, Dennerquist V, Wadell G, Arnberg N. Adenovirus type 11 uses CD46 as a cellular receptor. J Virol 2003;, 77, 9183-9191.
30. Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003; 9: 1408-1412.
31. Sirena D, Lilienfeld B, Eisenhut M, Kalin S, Boucke K, Beerli RR et al. The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J Virol 2004; 78: 4454-4462.
32. Davis GD, Elisee C, Newham DM, Harrison RG. New fusion protein systems designed to give soluble expression in Escherichia coli. Biotechnol Bioeng 1999; 65: 382-388.
33. Koike S, Horie H, Ise I, Okitsu A, Yoshida M, Iizuka N et al. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J 1990; 9: 3217-3224.
34. Damico R, Bates P. Soluble receptor-induced retroviral infection of receptor-deficient cells. J Virol 2000; 74: 6469-6475.
35. Lopez M, Cocchi F, Avitabile E, Leclerc A, Adelaide J, Campadelli-Fiume G et al. Novel, soluble isoform of the herpes simplex virus (HSV) receptor nectin1 (or PRR1-HIgR-HveC) modulates positively and negatively susceptibility to HSV infection. J Virol 2001; 75: 5684-5691.
36. Koizumi N, Mizuguchi H, Hosono T, Ishii-Watabe A, Uchida E, Utoguchi N et al. Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide. Biochem Biophys Acta 2001; 1568: 13-20.
37. Spear PG, Eisenberg RJ, Cohen GH. Three classes of cell surface receptors for alphaherpesvirus entry. Virology 2000; 275: 1-8.
38. Sakurai F, Mizuguchi H, Hayakawa T. Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector. Gene Therapy 2003; 10: 1041-1048.
39. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22: 4673-4680.
40. Saitou N, Nei M. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4: 406-425.
41. Kumar S, Tamura K, Nei M. MMGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 2004; 5: 150-163.